Replies to post #77919 on Biotech Values

[DewDiligence]

ISRG: No offense, but you people are clueless with regard to Intuitive. The number of procedures during Q1 grew an astounding 60% year over year to 45,000 (180,000 annualized).

Year-over-year growth rates can be misleading at an inflection point. This is not to say that there has in fact been an inflection point in ISRG’s business, but if there has been you might not see it in the YoY numbers.

What was the quarter-over-quarter growth in procedures? I couldn’t find the 4Q08 procedure count in the prior threads on this board. T.i.a.

[bridgeofsighs]

clueless with regard to Intuitive.
I am just looking at the sequential numbers as I do with all growth medical technology companies it is a very good way to spot the slowdown. I think saying I am clueless because my opinion is different then yours is combative for no reason.